Nom du produit:1-Cyclobutyl-6-fluoro-3-methyl-1H-indazole
IUPAC Name:1-cyclobutyl-6-fluoro-3-methyl-1H-indazole
- CAS：885271-99-8
- Formule moléculaire：C12H13FN2
- Pureté：95%
- Numéro de catalogue：CM150008
- Poids moléculaire：204.25
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:885271-99-8
- Formule moléculaire:C12H13FN2
- Point de fusion:-
- Code SMILES:CC1=NN(C2CCC2)C3=C1C=CC(F)=C3
- Densité:
- Numéro de catalogue:CM150008
- Poids moléculaire:204.25
- Point d'ébullition:
- N° Mdl:MFCD06658414
- Stockage:
Category Infos
- Indazoles
- Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.
- Cyclobutanes
- The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Recherche 
+86 21 5895 0110 
